About miDiagnostics
miDiagnostics is a company based in Leuven (Belgium) founded in 2015.. miDiagnostics has raised $112.75 million across 4 funding rounds from investors including Thermo Fisher Scientific, Imec and Johns Hopkins University. The company has 93 employees as of December 31, 2022. miDiagnostics offers products and services including nanoFluidic Processor, PCR Card, Reader, and Software. miDiagnostics operates in a competitive market with competitors including Biological Dynamics, Nanosphere, Anteo Tech, Genomic Vision and Aligned Bio, among others.
- Headquarter Leuven, Belgium
- Employees 93 as on 31 Dec, 2022
-
Sectors
Technology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Midiagnostics
-
Annual Revenue
$12.59 M (USD)0as on Dec 31, 2017
-
Net Profit
$-12.52 M (USD)2as on Dec 31, 2019
-
EBITDA
-
Total Equity Funding
$112.75 M (USD)
in 4 rounds
-
Latest Funding Round
$31.52 M (USD), Series D
Dec 03, 2024
-
Investors
Thermo Fisher Scientific
& 12 more
-
Employee Count
93
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miDiagnostics
miDiagnostics offers a comprehensive portfolio of products and services, including nanoFluidic Processor, PCR Card, Reader, and Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables high-precision, fast testing at low cost for molecular diagnostics.
Facilitates sample processing with nanometer precision for accurate results.
Processes tests and provides results in under 30 minutes.
Supports protocols for lab information systems and result traceability.
Unlock access to complete
Unlock access to complete
Funding Insights of miDiagnostics
miDiagnostics has successfully raised a total of $112.75M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $31.52 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $31.5M
-
First Round
First Round
(01 Jun 2015)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series D - miDiagnostics | Valuation | Thermo Fisher Scientific | |
| Mar, 2020 | Amount | Series B - miDiagnostics | Valuation | Urbain Vandeurzen | |
| Sep, 2018 | Amount | Grant - miDiagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in miDiagnostics
miDiagnostics has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Thermo Fisher Scientific, Imec and Johns Hopkins University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alychlo is engaged in investment activities supporting entrepreneurial dreams.
|
Founded Year | Domain | Location | |
|
Pamica is recognized as a growing industrial and service conglomerate.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by miDiagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - miDiagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Midiagnostics Comparisons
Competitors of miDiagnostics
miDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Nanosphere, Anteo Tech, Genomic Vision and Aligned Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| domain | founded_year | HQ Location |
Coupling reagents are developed for biomolecules immobilization on surfaces.
|
|
| domain | founded_year | HQ Location |
Single DNA molecules are analyzed via nanotechnology for cancer diagnostics.
|
|
| domain | founded_year | HQ Location |
Nanowire-based sensors and alignment technologies are provided for molecular detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Midiagnostics
Frequently Asked Questions about miDiagnostics
When was miDiagnostics founded?
miDiagnostics was founded in 2015.
Where is miDiagnostics located?
miDiagnostics is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Who is the current CEO of miDiagnostics?
Katleen Verleysen is the current CEO of miDiagnostics.
Is miDiagnostics a funded company?
miDiagnostics is a funded company, having raised a total of $112.75M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jun 01, 2015.
How many employees does miDiagnostics have?
As of Dec 31, 2022, the latest employee count at miDiagnostics is 93.
What is the annual revenue of miDiagnostics?
Annual revenue of miDiagnostics is $12.59M as on Dec 31, 2017.
What does miDiagnostics do?
MiDiagnostics was founded in 2015 as a joint venture between IMEC and Johns Hopkins University, based in Leuven, Belgium. Disposable chips are created using immunochemistry and nanotechnology to analyze biomarkers from a single blood drop for diagnosing cancer, infectious diseases, and cardiometabolic conditions like diabetes and cholesterol monitoring. Integration with an app enables data sharing with physicians and caregivers, and a consumer device is also offered.
Who are the top competitors of miDiagnostics?
miDiagnostics's top competitors include Biological Dynamics, Anteo Tech and Nanosphere.
What products or services does miDiagnostics offer?
miDiagnostics offers nanoFluidic Processor, PCR Card, Reader, and Software.
Who are miDiagnostics's investors?
miDiagnostics has 13 investors. Key investors include Thermo Fisher Scientific, Imec, Johns Hopkins University, PMV, and VLAIO.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.